Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSErtugliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 0.927 nM for the human enzyme).1 It is selective for SGLT2 over SGLT1 (IC50 = 2,050 nM for the human enzyme). Ertugliflozin increases urinary glucose excretion in rats in a dose-dependent manner. Formulations containing ertugliflozin have been used in the treatment of type 2 diabetes.
WARNING This product is not for human or veterinary use.
1. Discovery of a clinical candidate from the structurally unique dioxa-